Glaucoma: the retina and beyond

Area of Science:

• Ophthalmology
• Neuroscience
• Medical Imaging

Background:

• Glaucoma affects over 60 million worldwide, causing irreversible blindness due to optic nerve damage and retinal ganglion cell (RGC) loss.
• Intraocular pressure (IOP) is the only modifiable risk factor, but vision loss can persist even with controlled IOP.
• Current diagnostic methods often detect glaucoma late, necessitating advanced early detection strategies.

Purpose of the Study:

• To review current understanding of RGC and axonal loss mechanisms in glaucoma.
• To explore similarities between glaucoma and other central nervous system neurodegenerative diseases.
• To overview recent advancements in RGC health monitoring and early glaucoma diagnosis.

Main Methods:

• Literature review of mechanisms underlying RGC and axonal loss.
• Comparison of glaucoma with other neurodegenerative diseases.
• Examination of novel diagnostic techniques, including RGC-specific contrast agents and MRI for visual pathway assessment.

Main Results:

• Glaucoma shares mechanisms with other neurodegenerative conditions.
• New techniques are emerging for monitoring RGC health and early disease detection.
• MRI can assess glaucomatous changes in the brain's visual centers.

Conclusions:

• Early diagnosis of glaucoma is critical due to irreversible vision loss.
• Novel RGC monitoring and brain imaging techniques show promise for earlier detection and management.
• Understanding central nervous system changes in glaucoma is vital for clinical relevance.